Inactive

The Regional Health Contracting Office - Pacific at Tripler Army Medical Center (TAMC), Hawaii intends to award a firm fixed-price, non-personal contract for genomic-based laboratory services for Onco... The Regional Health Contracting Office - Pacific at Tripler Army Medical Center (TAMC), Hawaii intends to award a firm fixed-price, non-personal contract for genomic-based laboratory services for Oncotype DX testing for the Department of Pathology at TAMC, HI. This requirement is for a period of performance from 1 March 2020 through 28 February 2021, plus four (4), one (1) year option periods. The proposed acquisition is intended as a sole source to Genomic Health, Inc., as they are the only organization that can provide specialized Oncotype DX testing that is patented and can only be provided by them. This notice is neither a request for quotes nor a solicitation of offers; however, all responsible sources may submit a capability statement or quotation which shall be considered by the agency. The NAICS code of this procurement is 621511 and the size standard is $35M.

Inactive

This is a Sources Sought Notice. This is NOT a solicitation for proposals, proposal abstracts or quotations. The purpose of this notice is to obtain information regarding the availability and capabili... This is a Sources Sought Notice. This is NOT a solicitation for proposals, proposal abstracts or quotations. The purpose of this notice is to obtain information regarding the availability and capability of qualified sources and whether or not to conduct this procurement on a competitive basis. The NAICS code is 621511 and the size standard is $35M. Your responses to the information requested will assist the Government in determining the appropriate acquisition method. The Government intends to award a Firm Fixed-Price contract to the successful offeror. Tripler Army Medical Center (TAMC) has a requirement for Oncotype DX testing services for the Department of Pathology at TAMC, Hawaii. The laboratory will provide clinically-validated molecular diagnostics with individualized information on response to certain types of therapy, as well as the likelihood of disease recurrence. The Regional Health Contracting Office-Pacific intends to acquire a commercial item using FAR Part 12. This procurement is being conducted under FAR Part 13 Simplified Acquisition Procedures. Interested organizations may submit their capabilities and qualifications to perform the effort in writing no later than 6 FEB 2020 at 10:00 AM Hawaii Standard Time. A determination by the Government not to compete this proposed effort on a full and open competition basis, based upon responses to this notice, is solely within the discretion of the Government. Vendors are invited to submit information demonstrating their ability to fulfill the requirement in the form of a capability response that addresses the specific requirement identified in this notice. Responses to this notice should include company name, address, telephone number, point of contact (POC), and brochures which will allow the Government to understand your offerings and options. Capability statements should be submitted to the attention of Charis Naito, Contract Specialist, Regional Health Contracting Office - Pacific; email charis.k.naito.civ@mail.mil. Telephone responses will not be accepted. All vendors providing to the Federal Government are required to be registered in the System for Award Management (SAM) registry with NAICS code 621511. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to provide the required services. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential or sensitive information should be included in your response.